Answer extracted from the Proven Podcast — listen to the full episode below.
Why does American healthcare cost 40% of global spending when the US is only 3% of the world population?
The United States operates the only free enterprise healthcare system on earth where prices are not controlled and hospitals and doctors are not employees or owned by the state. Because innovators make the bulk of their money from the American market, almost all medical innovation globally is designed for Americans. This concentration of spending drives worldwide healthcare advancement, meaning the quality of healthcare everywhere else on earth fundamentally depends on the U.S. system.
Why America's healthcare market controls global innovation
Most developed nations use government-controlled healthcare systems where prices and providers are centrally managed. The United States stands alone with a marketplace where hospitals, doctors, and pharmaceutical companies set their own prices based on demand and competition. As discussed in this episode of Proven Podcast, this system has an unintended consequence: it attracts all the money.
Medical innovators—pharmaceutical companies, device manufacturers, biotech firms—know that the American market is where they capture the majority of their profits. Whether it's a breakthrough cancer treatment, a new surgical device, or a vaccine, companies invest in development because Americans can and do pay premium prices. Countries with fixed-price healthcare systems don't generate the same financial returns, so they become secondary markets for innovations designed and proven in America first.
This creates a global dependency that often goes unnoticed. When a European patient receives a cutting-edge treatment, the research, clinical trials, and manufacturing scale that made it possible were funded by American healthcare spending. As David Goldhill explains in the conversation, America drives 40% of world healthcare spend—a disproportionate share that bankrolls the innovation pipeline for every other developed nation.
The profit motive that nobody talks about
In government-controlled systems, healthcare providers—hospitals, doctors, pharmaceutical manufacturers—cannot profit from lowering costs or improving efficiency in ways that reduce overall revenue. The financial incentive structure is fundamentally different. But in America's free market, nobody in the healthcare system can make more money by lowering their prices. Every actor—from hospital administrators to pharmaceutical executives—benefits from higher prices, more procedures, and premium positioning.
This means there is no built-in pressure to reduce costs or simplify the system. A doctor makes more money performing an expensive procedure than a cheap one. A hospital builds more revenue from costly treatments. A drug company prices a medication as high as the market will bear. When you combine this profit structure with the fact that most American patients are insulated from prices through insurance, the result is systematic cost inflation. The free market, in this case, has failed to produce the price discipline that exists in every other developed nation.
"Nobody in the healthcare system can make more money, can be more profitable by lowering their prices."
David Goldhill — Founder and CEO of Sesame, a healthcare marketplace. Goldhill spent decades as an entertainment executive, running television divisions at Universal Studios and the Game Show Network before pivoting to healthcare innovation. His career shift was driven by a personal tragedy that exposed the dysfunction in America's healthcare pricing model.
Curious about the specific marketplace solutions Goldhill is building at Sesame to break this cycle? Hear the full episode where he details how transparency and direct pricing can compete with the traditional insurance-driven model.
Key takeaways
- The U.S. is the only developed nation with a free enterprise healthcare system where providers and pharmaceutical companies control pricing without state oversight.
- Medical innovators concentrate their investment in the American market because that's where they earn the majority of their revenue, making the U.S. the birthplace of almost all global healthcare innovation.
- The 40% of world healthcare spending that flows through the U.S. system subsidizes healthcare advancement for every other developed nation.
- In America's system, there is no financial incentive for providers to lower prices or reduce costs—every actor profits from higher spending, unlike government-controlled systems elsewhere.
See also
How can business owners transition wealth from active business to passive asset income?
Many entrepreneurs become one-dimensional with all wealth tied to their business. The solution is to deliberately pull money off the table into passive assets that generate independent income streams.
Why should investors focus on their investor DNA rather than diversifying prematurely?
Investor DNA means understanding who you are as an investor and what asset classes you excel at managing—whether real estate, business acquisitions, or other opportunities that align with your strengths.
What tax arbitrage strategies allow business owners to spend less than they save?
Tax arbitrage means spending a dollar to get more than a dollar back through tax benefits. Examples include historic easements where you preserve a facade and receive significant tax deductions.